WHO approves vaccine against monkeypox from Nordic Bavaria

Queen

WHO approves vaccine against monkeypox from Nordic Bavaria

The approval of a new vaccine means that it has been included in the reference list; it can be used by countries that do not have the financial and technical capacity to carry out scientific tests of such preparations.

Monkeypox has been spreading in Africa for some time. The Democratic Republic of Congo is the most affected by the epidemic, where, according to data from July 28, 37,500 cases of illness and 1,451 deaths have been recorded. According to the Africa Centers for Infectious Disease Prevention (CDC), cases of infection have been confirmed in 15 African countries.

The first vaccination campaign, with 265,000 doses of the Bavarian Nordic vaccine, will take place in the DRC and is scheduled for early October.

Monkeypox is a contagious infection that causes a rash and flu-like symptoms. The disease is usually harmless, but in some cases it can be fatal (PAP).

ahm/adjustment/

Source link

Leave a Comment